Medpace Holdings, Inc. to Present at Jefferies 2019 Healthcare Conference
CINCINNATI--(BUSINESS WIRE)--May 21, 2019--
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will present at the following investor conference in June:
Jefferies 2019 Healthcare Conference
Location: New York, NY
Date: Tuesday, June 4, 2019
Presentation: 8:30 a.m. ET
Speakers: August Troendle, President & Chief Executive Officer, and Jesse Geiger, Chief Financial Officer & Chief Operating Officer, Laboratory Operations
A live webcast of each presentation will be accessible through the “Investors” section of the Company’s website at www.medpace.com and will be available for replay following each event.
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical, and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system, and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 3,100 people across 36 countries.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190521005857/en/
CONTACT: Media Contact:
Medpace Holdings, Inc.
KEYWORD: UNITED STATES NORTH AMERICA NEW YORK OHIO
INDUSTRY KEYWORD: SURGERY HEALTH BIOTECHNOLOGY CARDIOLOGY HOSPITALS MEDICAL DEVICES ONCOLOGY PHARMACEUTICAL PROFESSIONAL SERVICES BANKING FINANCE OTHER PROFESSIONAL SERVICES
SOURCE: Medpace Holdings, Inc.
Copyright Business Wire 2019.
PUB: 05/21/2019 04:05 PM/DISC: 05/21/2019 04:05 PM